Regional changes over time in initial virologic response rates to combination antiretroviral therapy across EuropeBANNISTER, Wendy P; KIRK, Ole; GATELL, Jose M et al.Journal of acquired immune deficiency syndromes (1999). 2006, Vol 42, Num 2, pp 229-237, issn 1525-4135, 9 p.Article

Virologic, immunologic, and clinical benefits from early combined antiretroviral therapy in infants with perinatal HIV-1 infectionCHIAPPINI, Elena; GALLI, Luisa; TOVO, Pier-Angelo et al.AIDS (London). 2006, Vol 20, Num 2, pp 207-215, issn 0269-9370, 9 p.Article

Incidence of Tuberculosis in HIV-Infected Patients Before and After Starting Combined Antiretroviral Therapy in 8 Sub-Saharan African HIV ProgramsNICHOLAS, Sarala; SABAPATHY, Kalpana; FERREYRA, Cecilia et al.Journal of acquired immune deficiency syndromes (1999). 2011, Vol 57, Num 4, pp 311-318, issn 1525-4135, 8 p.Article

Modulation of the complement system in monocytes contributes to tuberculosis-associated immune reconstitution inflammatory syndromeTRAN, Huyen T. T; VAN DEN BERGH, Rafael; RAES, Geert et al.AIDS (London). 2013, Vol 27, Num 11, pp 1725-1734, issn 0269-9370, 10 p.Article

The Impact of HIV Viral Control on the Incidence of HIV-Associated Anal CancerCHIAO, Elizabeth Y; HARTMAN, Christine M; EL-SERAG, Hashem B et al.Journal of acquired immune deficiency syndromes (1999). 2013, Vol 63, Num 5, pp 631-638, issn 1525-4135, 8 p.Article

Pharmacokinetics, Safety, and Efficacy of Tipranavir Boosted With Ritonavir Alone or in Combination With Other Boosted Protease Inhibitors as Part of Optimized Combination Antiretroviral Therapy in Highly Treatment-Experienced Patients (Bl Study 1182.51)WALMSLEY, Sharon L; KATLAMA, Christine; LAZZARIN, Adriano et al.Journal of acquired immune deficiency syndromes (1999). 2008, Vol 47, Num 4, pp 429-440, issn 1525-4135, 12 p.Article

Response to combination antiretroviral therapy : variation by ageAIDS (London). 2008, Vol 22, Num 12, pp 1463-1473, issn 0269-9370, 11 p.Article

Antiretroviral monotherapy: should we abandon the principles of successful antiretroviral therapy?BATTEGAY, Manuel; BUCHER, Heiner C.AIDS (London). 2010, Vol 24, Num 7, pp 1057-1059, issn 0269-9370, 3 p.Article

Risk factors for osteonecrosis in HIV-infected patients : impact of treatment with combination antiretroviral therapyMARY-KRAUSE, Murielle; BILLAUD, Eric; POIZOT-MARTIN, Isabelle et al.AIDS (London). 2006, Vol 20, Num 12, pp 1627-1635, issn 0269-9370, 9 p.Article

HIV-associated neurocognitive disorders before and during the era of combination antiretroviral therapy: differences in rates, nature, and predictorsHEATON, Robert K; FRANKLIN, Donald R; COLLIER, Ann C et al.Journal of neurovirology. 2011, Vol 17, Num 1, pp 3-16, issn 1355-0284, 14 p.Article

L'epidemia da HIV/AIDS in Provincia di Sassari nell'era della terapia antiretrovirale combinata = (The HIV/AIDS epidemic in the Province of Sassari in the combination antiretroviral therapy era)MADEDDU, Giordano; CALIA, Giovanna Maria; LOVIGU, Carla et al.Annali dell' Istituto superiore di sanità. 2006, Vol 42, Num 2, pp 197-202, issn 0021-2571, 6 p.Article

Changing patterns of clinical events in perinatally HIV-1-infected children during the era of HAARTCHIAPPINI, Elena; GALLI, Luisa; GUARINO, Alfredo et al.AIDS (London). 2007, Vol 21, Num 12, pp 1607-1615, issn 0269-9370, 9 p.Article

High prevalence of severe vitamin D deficiency in combined antiretroviral therapy-naive and successfully treated Swiss HIV patientsMUELLER, Nicolas J; FUX, Christoph A; LEDERGERBER, Bruno et al.AIDS (London). 2010, Vol 24, Num 8, pp 1127-1134, issn 0269-9370, 8 p.Article

Detection of peripheral HIV-1-specific memory B cells in patients untreated or receiving highly active antiretroviral therapyFONDERE, Jean-Michel; HUGUET, Marie-France; YSSEL, Hans et al.AIDS (London). 2003, Vol 17, Num 16, pp 2323-2330, issn 0269-9370, 8 p.Article

Immunologic, Virologic, and Clinical Consequences of Episodes of Transient Viremia During Suppressive Combination Antiretroviral TherapyVAN SIGHEM, Ard; SHUANGJIE ZHANG; REISS, Peter et al.Journal of acquired immune deficiency syndromes (1999). 2008, Vol 48, Num 1, pp 104-108, issn 1525-4135, 5 p.Article

Decline of CD4⁺ T-cell count before start of therapy and immunological response to treatment in antiretroviral-naive individualsMUSSINI, Cristina; COSSARIZZA, Andrea; SABIN, Caroline et al.AIDS (London). 2011, Vol 25, Num 8, pp 1041-1049, issn 0269-9370, 9 p.Article

Lower mortality and earlier start of combination antiretroviral therapy in patients tested repeatedly for HIV than in those with a positive first testGRAS, Luuk; VAN SIGHEM, Ard; BEZEMER, Daniela et al.AIDS (London). 2011, Vol 25, Num 6, pp 813-818, issn 0269-9370, 6 p.Article

Abacavir once or twice daily combined with once-daily lamivudine and efavirenz for the treatment of antiretroviral-naive HIV-infected adults: Results of the Ziagen Once Daily in Antiretroviral Combination StudyMOYLE, Graeme J; DEJESUS, Edwin; CAHN, Pedro et al.Journal of acquired immune deficiency syndromes (1999). 2005, Vol 38, Num 4, pp 417-425, issn 1525-4135, 9 p.Article

Prognostic factors for survival in human immunodeficiency virus-associated pulmonary arterial hypertensionNUNES, Hilario; HUMBERT, Marc; BARST, Robyn J et al.American journal of respiratory and critical care medicine. 2003, Vol 167, Num 10, pp 1433-1439, issn 1073-449X, 7 p.Article

Immunological and virological responses to combined antiretroviral therapy in HIV/hepatitis B virus-coinfected patients from a multicenter cohortHUANLING WANG; YIJIA LI; CHENGDA ZHANG et al.AIDS (London). 2012, Vol 26, Num 14, pp 1755-1763, issn 0269-9370, 9 p.Article

Combined antiretroviral therapy reduces hyperimmunoglobulinemia in HIV-1 infected childrenAIDS (London). 2004, Vol 18, Num 10, pp 1423-1428, issn 0269-9370, 6 p.Article

Low plasma levels of the soluble receptor for advanced glycation end products in HIV-infected patients with subclinical carotid atherosclerosis receiving combined antiretroviral therapySU JIN JEONG; CHANG OH KIM; JUNE MYUNG KIM et al.Atherosclerosis. 2011, Vol 219, Num 2, pp 778-783, issn 0021-9150, 6 p.Article

Combination antiretroviral therapy modulates the blood oxygen level-dependent amplitude in human immunodeficiency virus-seropositive patientsANCES, Beau M; ROC, Anne C; KORCZYKOWSKI, Marc et al.Journal of neurovirology. 2008, Vol 14, Num 5, pp 418-424, issn 1355-0284, 7 p.Article

The effects of HIV and combination antiretroviral therapy on white matter integrityWRIGHT, Patrick W; HEAPS, Jodi M; SHIMONY, Josh S et al.AIDS (London). 2012, Vol 26, Num 12, pp 1501-1508, issn 0269-9370, 8 p.Article

Once-Daily Atazanavir/Ritonavir Compared With Twice-Daily Lopinavir/Ritonavir, Each in Combination With Tenofovir and Emtricitabine, for Management of Antiretroviral-Naive HIV-1-Infected Patients: 96-Week Efficacy and Safety Results of the CASTLE StudyMOLINA, Jean-Michel; ANDRADE-VILLANUEVA, Jaime; WIRTZ, Victoria et al.Journal of acquired immune deficiency syndromes (1999). 2010, Vol 53, Num 3, pp 323-332, issn 1525-4135, 10 p.Article